Press releases

FDA Approves VAXELIS™, Sanofi and MSD’s Pediatric Hexavalent Combination Vaccine

Dengvaxia® vaccine approved for prevention of dengue in Europe

Sanofi receives positive CHMP opinion for dengue vaccine

Sanofi to invest €350 million in Canadian vaccine facility

Sanofi ends development of <em>Clostridium difficile</em> vaccine

Sanofi updates information on dengue vaccine

Sanofi invests €170 million in new vaccine production facility in France

Sanofi completes the acquisition of Protein Sciences

Sanofi to acquire Protein Sciences

Sanofi Pasteur and MedImmune collaborate on monoclonal antibody to prevent illnesses associated with RSV

Sanofi Pasteur and MSD end joint vaccines business in Europe

Sanofi Pasteur and MSD confirm closing date to end the joint vaccines operations in Europe

Sanofi Pasteur, Fiocruz, and WRAIR Agree to collaborate on zika vaccine research

The eradication of poliomyelitis is in sight

Cannes Corporate Media &amp; TV Awards recognize Sanofi Pasteur’s corporate film 'It Happened'

First dengue vaccine approved in more than 10 countries

BARDA grants $43.2 million USD to Sanofi Pasteur for zika

Mexico starts dengue vaccinations

Dengue immunization public program in Paraná State of Brazil set to achieve WHO 2020 ambition

Sanofi Pasteur signs research agreement for zika vaccine

Strategic advisory group of experts on immunization convened by the World Health Organization recommends use of Sanofi Pasteur’s dengue vaccine in endemic countries

World’s first public dengue immunization program starts in the Philippines

Sanofi Pasteur and MSD (known as Merck in the United States and Canada) announce intent to end joint vaccines operations in Europe, Sanofi Pasteur MSD, to pursue their own distinct growth strategies

First Vaccinations against Dengue mark historic moment in prevention of infectious diseases

Sanofi Pasteur to leverage its strong vaccine legacy in hunt for zika vaccine

Sanofi Pasteur provides key support to the human vaccines project

Dengvaxia^® first dengue vaccine approved in Brazil

Sanofi Pasteur’s dengue vaccine approved in the Philippines

Dengvaxia^®, world’s first dengue vaccine, approved in Mexico

First doses of injectable polio vaccine ShanIPV™ soon available for Indian infants

Sanofi Pasteur reveals its research on a "universal" influenza vaccine

<em>New England Journal of Medicine</em> publishes new analyses confirming that Sanofi Pasteur’s vaccine candidate safely protects pre-adolescents to adults against dengue

Shantha will provide up to 37 million doses of Shan5™